Notification for retail price fixation of 11 new drugs
The National Pharmaceutical Pricing Authority fixes the retail prices for eleven specified drug formulations, exclusive of Goods and Services Tax, effective from August 27, 2026.
196 gazette notifications — Page 1 of 4
The National Pharmaceutical Pricing Authority fixes the retail prices for eleven specified drug formulations, exclusive of Goods and Services Tax, effective from August 27, 2026.
This notification is an addendum to the National Pharmaceutical Pricing Authority's previous order, adding new entries for the ceiling price of Mannitol Injection and including M/s Silica Healthcare P…
M/s G.S. Pharmbutor Private Limited is exempted from the provisions of the Drugs (Prices Control) Order, 2013 under para 32(iii) for the formulation “Povidone Iodine Throat Spray 0.45% w/v” for a peri…
This notification issues an addendum to previous orders by the National Pharmaceutical Pricing Authority, incorporating M/s Indbest Healthcare Pvt. Ltd. and its product "PP bottles- Dual Port cap" int…
The National Pharmaceutical Pricing Authority fixes the retail prices for specified drug formulations, exclusive of Goods and Services Tax, in implementation of a review order and in exercise of power…
The National Pharmaceutical Pricing Authority fixes the retail prices for specific pharmaceutical formulations under the Drugs (Prices Control) Order, 2013.
This addendum modifies previous orders of the National Pharmaceutical Pricing Authority by including M/s Silica Healthcare Pvt. Ltd. and its specified Ringer Lactate products in Table 'B' and clarifyi…
The Government of India announces the 'Scheme for Chemicals Parks – Bharat Audyogik Vikas Yojana – Rasayan (BHAVYA Rasayan) Scheme' for the establishment of three dedicated Chemical Parks.
The National Pharmaceutical Pricing Authority fixes the retail prices for 23 specified pharmaceutical formulations, exclusive of Goods and Services Tax.
The National Pharmaceutical Pricing Authority fixes the retail prices for thirty-nine specific drug formulations, exclusive of Goods and Services Tax, under the Drugs (Prices Control) Order, 2013.
This addendum modifies previous orders issued by the National Pharmaceutical Pricing Authority regarding the ceiling price fixation of scheduled formulation packs of I.V. fluids by incorporating M/s S…
This addendum modifies the National Pharmaceutical Pricing Authority's Order No. 1584(E) dated 25th March 2026, regarding the ceiling price fixation of scheduled formulation packs of Ringer Lactate (n…
The National Pharmaceutical Pricing Authority fixes/revises the ceiling price for the scheduled formulation Anti-rabies immunoglobulin injection 300 IU/ml.
This Order amends the n-Butyl Acrylate (Quality Control) Order, 2021, by substituting the date "10th July, 2026" with "31st July, 2026" in paragraph 2, proviso, to temporarily extend the suspension of…
M/s Biological E Limited is exempted from the provisions of the Drugs (Prices Control) Order, 2013 under Para 32(i) & 32(ii) for their formulation 'Pneumococcal Polysaccharide Conjugate Vaccine (PNEUB…
The National Pharmaceutical Pricing Authority fixes the retail price for "Glycopyrronium 25 mcg + Formoterol Fumarate 20 mcg + Budesonide 500 mcg Smartules" manufactured by M/s Glenmark Pharmaceutical…
The Central Government issues an Order further to amend the Drugs (Prices Control) Order, 2013, in exercise of powers conferred by section 3 of the Essential Commodities Act, 1955.
The Central Government amends the Linear Alkyl Benzene (Quality Control) Order, 2022, to temporarily suspend its operation by substituting a specific period in its proviso.
The National Pharmaceutical Pricing Authority fixes and revises the ceiling prices for BCG Vaccine, Measles Rubella Vaccine, and Measles Vaccine, including a WPI impact, under paragraph 19 of the Drug…
The National Pharmaceutical Pricing Authority fixes revised ceiling prices for Anti-Tetanus Immunoglobulin 250 IU and 500 IU Injections by allowing a one-time 50% increase over prevailing prices under…
The National Pharmaceutical Pricing Authority fixes revised ceiling prices for Carboplatin 10 mg/ml Injection and Cisplatin 1 mg/ml Injection in public interest, exercising extraordinary powers under …
The National Pharmaceutical Pricing Authority fixes the retail prices for 30 specific drug formulations, exclusive of Goods and Services Tax, under the provisions of the Drugs (Prices Control) Order, …
The National Pharmaceutical Pricing Authority fixes/revises the ceiling price for Benzathine benzylpenicillin, a scheduled formulation, including a WPI impact of 0.64956% for the year 2026.
This corrigendum issued by the National Pharmaceutical Pricing Authority corrects the manufacturer and product/brand names in Table-B, Sl. No. 4, of its previous notification S.O. 1584(E), dated 25.03…
Shri Sd. Aminur Rahman is designated as an "Estate Officer" for Bengal Chemicals & Pharmaceuticals Ltd. (BCPL) under Section 3(a) of the Public Premises (Eviction of Unauthorized Occupant) Act, 1971.
The National Pharmaceutical Pricing Authority fixes the retail prices for 42 specified pharmaceutical formulations, exclusive of Goods and Services Tax, under the powers conferred by the Drugs (Prices…
The National Pharmaceutical Pricing Authority issues an Addendum to its Order No. 1583(E) dated 25.03.2026, concerning ceiling price fixation of scheduled formulation packs of I.V. fluids.
The Central Government appoints Justice Shri G.S. Ahluwalia as Commissioner for the welfare of the victims of the Bhopal gas leak disaster under the Bhopal Gas Leak Disaster (Processing of Claims) Act…
The Central Government amends the n-Butyl Acrylate (Quality Control) Order, 2021, to temporarily suspend the applicability of Indian Standards for n-Butyl Acrylate from April 10, 2026, to July 10, 202…
The Central Government amends the Morpholine (Quality Control) Order, 2020, to temporarily suspend the applicability of Indian Standard conformity for Morpholine from April 1, 2026, to July 1, 2026.
This order amends the Linear Alkyl Benzene (Quality Control) Order, 2022, to temporarily suspend the applicability of Indian Standards for Linear Alkyl Benzene.
The National Pharmaceutical Pricing Authority revises the ceiling prices for specific scheduled formulations, including Piperacillin (A) + Tazobactam (B) Injection, based on the Wholesale Price Index …
This order fixes the ceiling prices for 138 scheduled formulations based on an annual Wholesale Price Index increase, effective from April 1, 2026.
The National Pharmaceutical Pricing Authority revises the ceiling prices for specific scheduled formulations based on the Wholesale Price Index (WPI) of 2025, effective from April 1, 2026.
The National Pharmaceutical Pricing Authority revises the ceiling prices for specified scheduled formulations, including Meropenem, based on the Wholesale Price Index (WPI) of 2025 with a 0.64956% inc…
The National Pharmaceutical Pricing Authority fixes the retail prices for various drug formulations as specified in the accompanying table, exclusive of Goods and Services Tax.
The National Pharmaceutical Pricing Authority revises the ceiling prices for specified scheduled formulations based on the Wholesale Price Index (WPI) of 2025, effective from April 1, 2026.
The National Pharmaceutical Pricing Authority revises the ceiling prices for specific scheduled formulations based on the Wholesale Price Index (WPI) of 2025 with a 0.64956% increase, effective from A…
This Order grants M/s Intas Pharmaceuticals Limited an exemption from the provisions of para 32(ii) of the Drugs (Prices Control) Order, 2013 for their Clozapine Extended Release Capsules 12.5 mg / 25…
This Order revises the ceiling prices of Coronary Stents, effective from April 1, 2026, by the National Pharmaceutical Pricing Authority.
The National Pharmaceutical Pricing Authority fixes ceiling prices for 767 Scheduled formulations, effective from April 1, 2026, incorporating an annual Wholesale Price Index (WPI) increase of 0.64956…
This Corrigendum amends the manufacturer and marketing company names for specific entries in the National Pharmaceutical Pricing Authority's retail price fixation notification S.O. 575(E), dated 09.02…
The National Pharmaceutical Pricing Authority fixes revised ceiling prices for specific scheduled formulations, exclusive of Goods and Services Tax, effective from April 1, 2026, incorporating an annu…
The National Pharmaceutical Pricing Authority exempts M/s Wockhardt Limited from the provisions of the Drugs (Prices Control) Order, 2013 under para 32(i) for its formulation "Nafithromycin Tablets – …
This corrigendum amends the manufacturer and marketing company name for Sl. No. 7 in the National Pharmaceutical Pricing Authority's notification S.O. 5635(E), dated 02.11.2018, regarding retail price…
The National Pharmaceutical Pricing Authority fixes the retail price of specified formulations in exercise of powers conferred by the Drugs (Prices Control) Order, 2013.
This notification introduces the Council (National Institute of Pharmaceutical Education and Research) Amendment Rules, 2026, to amend the Council (National Institute of Pharmaceutical Education and R…
The notification mandates the use of Aadhaar for beneficiaries to avail ex-gratia compensation under the Bhopal Gas Leak Disaster (Registration and Processing of Claims) Scheme, 1985, as per Section 7…
The Government of India mandates the use of Aadhaar for establishing identity to receive ex-gratia compensation under the Bhopal Gas Leak Disaster (Registration and Processing of Claims) Scheme, 1985,…
The National Pharmaceutical Pricing Authority fixes the retail prices, exclusive of Goods and Services Tax, for 36 specified drug formulations with their respective strengths, units, and manufacturer/…